Literature DB >> 24052926

New method to visualize neurons with DAT in slices of rat VTA using fluorescent substrate for DAT, ASP+

Mikhail U Inyushin1, Francisco Arencibia-Albite, Angel de la Cruz, Rafael Vázquez-Torres, Katiria Colon, Priscila Sanabria, Carlos A Jiménez-Rivera.   

Abstract

The ventral tegmental area (VTA), and in particular dopamine (DA) neurons in this region of midbrain, has been shown to play an important role in motivation (goal-directed behavior), reward, and drug addiction. Most evidence that implicates VTA DA neurons in these functions are based on widely accepted but indirect electrophysiological characterization, including the hyperpolarization activated non-specific cation current (Ih), spike frequency, and inhibition by D2 receptor agonists. In this study, we used a known neuronal dopamine transporter (DAT) fluorescent substrate [4-(4- (dimethylamino) styryl)-N-methylpyridinium iodide] (ASP+) to visualize DAT-containing cell bodies of DA neurons in VTA region in rat brain slices. Uptake of 100 nM of ASP+ in brain slices of rat VTA region marked 38% of visible neurons, while other neurons from this region and 100% neurons from hippocampus slices were not fluorescent. Using patch-clamp techniques, we have found that pronounced Ih current was present in all fluorescent neurons from VTA area, also spike frequency was similar to the widely accepted values for DA neurons. Furthermore, additional study has shown that there are 84% coincidence of ASP+ fluorescence in neuronal cell bodies and Falck-Hillarp labeling of DA cells. Electrophysiological recordings during ASP+ application have confirmed that low concentrations (100 nM) of ASP+ have no visible effect on neuronal activity during 1-2 hours after staining. Thus, uptake of fluorescent monoamine analog ASP+ by DAT can be an additional criterion for identification of DAT-containing neurons in slices.

Entities:  

Keywords:  DAT fluorescent substrate; dopamine neurons; ventral tegmental area

Year:  2013        PMID: 24052926      PMCID: PMC3773718          DOI: 10.1166/jnsne.2013.1040

Source DB:  PubMed          Journal:  J Neurosci Neuroeng        ISSN: 2168-2011


  24 in total

1.  Mesoaccumbens dopamine neuron synapses reconstructed in vitro are glutamatergic.

Authors:  M P Joyce; S Rayport
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain.

Authors:  Henrike Neuhoff; Axel Neu; Birgit Liss; Jochen Roeper
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

3.  Dopaminergic neurons intrinsic to the primate striatum.

Authors:  R Betarbet; R Turner; V Chockkan; M R DeLong; K A Allers; J Walters; A I Levey; J T Greenamyre
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

4.  A comparison of axonal and somatodendritic dopamine release using in vivo dialysis.

Authors:  P W Kalivas; P Duffy
Journal:  J Neurochem       Date:  1991-03       Impact factor: 5.372

5.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

Authors:  A A Grace; B S Bunney
Journal:  Neuroscience       Date:  1983-10       Impact factor: 3.590

6.  Pharmacological characterization of dopamine transport in cultured rat astrocytes.

Authors:  M Inazu; N Kubota; H Takeda; J Zhang; Y Kiuchi; K Oguchi; T Matsumiya
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

7.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

8.  Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses.

Authors:  Nao Chuhma; Hui Zhang; Justine Masson; Xiaoxi Zhuang; David Sulzer; René Hen; Stephen Rayport
Journal:  J Neurosci       Date:  2004-01-28       Impact factor: 6.167

9.  Reliability in the identification of midbrain dopamine neurons.

Authors:  Elyssa B Margolis; Allison R Coker; Joseph R Driscoll; Anne-Iris Lemaître; Howard L Fields
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

10.  MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology.

Authors:  Jyothi K Mallajosyula; Deepinder Kaur; Shankar J Chinta; Subramanian Rajagopalan; Anand Rane; David G Nicholls; Donato A Di Monte; Heather Macarthur; Julie K Andersen
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more
  5 in total

Review 1.  Model systems for analysis of dopamine transporter function and regulation.

Authors:  Moriah J Hovde; Garret H Larson; Roxanne A Vaughan; James D Foster
Journal:  Neurochem Int       Date:  2018-09-01       Impact factor: 3.921

2.  Quinine enhances the behavioral stimulant effect of cocaine in mice.

Authors:  Adriana Huertas; William D Wessinger; Yuri V Kucheryavykh; Priscila Sanabria; Misty J Eaton; Serguei N Skatchkov; Legier V Rojas; Gerónimo Maldonado-Martínez; Mikhail Y Inyushin
Journal:  Pharmacol Biochem Behav       Date:  2014-12-05       Impact factor: 3.533

3.  Structural Similarities between Some Common Fluorophores Used in Biology, Marketed Drugs, Endogenous Metabolites, and Natural Products.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Mar Drugs       Date:  2020-11-23       Impact factor: 5.118

4.  The Probe for Renal Organic Cation Secretion (4-Dimethylaminostyryl)-N-Methylpyridinium (ASP+)) Shows Amplified Fluorescence by Binding to Albumin and Is Accumulated In Vivo.

Authors:  Jacob Schade Engbjerg; Vincenzo Costanzo; Donato Sardella; Luca Bordoni; Steen Jakobsen; Luciano D'Apolito; Jørgen Frøkiær; Francesco Trepiccione; Giovambattista Capasso; Sebastian Frische
Journal:  Mol Imaging       Date:  2022-03-22       Impact factor: 4.488

5.  A New Method for the Visualization of Living Dopaminergic Neurons and Prospects for Using It to Develop Targeted Drug Delivery to These Cells.

Authors:  Victor Blokhin; Alina V Lavrova; Sergey A Surkov; Eduard R Mingazov; Natalia M Gretskaya; Vladimir V Bezuglov; Michael V Ugrumov
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.